Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rachel C Wright"'
Autor:
Alfredo Erazo-Oliveras, Mónica Muñoz-Vega, Mohamed Mlih, Venkataramana Thiriveedi, Michael L. Salinas, Jaileen M. Rivera-Rodríguez, Eunjoo Kim, Rachel C. Wright, Xiaoli Wang, Kerstin K. Landrock, Jennifer S. Goldsby, Destiny A. Mullens, Jatin Roper, Jason Karpac, Robert S. Chapkin
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-28 (2023)
Abstract Although the role of the Wnt pathway in colon carcinogenesis has been described previously, it has been recently demonstrated that Wnt signaling originates from highly dynamic nano-assemblies at the plasma membrane. However, little is known
Externí odkaz:
https://doaj.org/article/3de4b617c802477bb155787654bcfdfe
Autor:
Natividad R. Fuentes, David N. McMurray, Michael L. Salinas, Robert S. Chapkin, Rachel C. Wright, Rachel Choate
Publikováno v:
Biophys J
The increasing prevalence of adult and adolescent obesity and its associated risk of colorectal cancer reinforces the urgent need to elucidate the underlying mechanisms contributing to the promotion of colon cancer in obese individuals. Adiponectin i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cdc38343839e10aee5489b25f751d66
https://doi.org/10.1016/j.bpj.2019.09.009
https://doi.org/10.1016/j.bpj.2019.09.009
Autor:
Bhakti K. Patel, Alec Kacew, Garth W. Strohbehn, Brian L. Heiss, Alexandra Cabanov, Keith Danahey, Thomas F. Gajewski, Natasha N Pettit, Rachel C Wright, Jennifer Pisano, Emily F. Higgs, Mark J. Ratain, Jeffrey Bloodworth, Cuoghi Edens, Pankti Reid, Jovian Yu, Iazsmin Bauer Ventura, Mary E. Strek, Theodore Karrison, Adriana Koziol, Jonathan A. Trujillo, Sherin J. Rouhani, Alexandra Weiss
Publikováno v:
Clinical Pharmacology & Therapeutics
medRxiv
medRxiv
Background Interleukin-6 (IL-6)-mediated hyperinflammation may contribute to the high mortality of coronavirus disease 2019 (Covid-19). Tocilizumab, an IL-6 receptor blocking monoclonal antibody, has been repurposed for Covid-19, but prospective tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cf667b85bde68e727c8a461f3712870
Autor:
Rachel C. Wright, Bradley R. Weeks, Robert S. Chapkin, Gus A. Wright, Clinton D. Allred, Kerstin K. Landrock, Laurie A. Davidson, Arul Jayaraman, Un Ho Jin, Grace Yoon, Ivan Ivanov, Yang Yi Fan, Jatin Roper, Huajun Han, Jennifer S. Goldsby, Stephen Safe
Publikováno v:
EMBO J
The aryl hydrocarbon receptor (AhR), a ligand‐activated transcription factor that senses xenobiotics, diet, and gut microbial‐derived metabolites, is increasingly recognized as a key regulator of intestinal biology. However, its effects on the fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea0b4ac8f4d5c1aaef9d336f3defd25d
https://doi.org/10.15252/embj.2019104319
https://doi.org/10.15252/embj.2019104319
Autor:
Cuoghi Edens, Pankti Reid, Rachel C Wright, Iazsmin Bauer Ventura, Jonathan A. Trujillo, Jennifer Pisano, Bhakti K. Patel, Mark J. Ratain, Keith Danahey, Mary E. Strek, Natasha N Pettit, Thomas F. Gajewski, Alexandra Cabanov, Sherin J. Rouhani, Garth W. Strohbehn, Jovian Yu, Brian L. Heiss, Theodore Karrison, Adriana Koziol, Emily F. Higgs, Alec Kacew, Jeffrey Bloodworth, Alexandra Weiss
Publikováno v:
Clinical Pharmacology and Therapeutics
BackgroundInterleukin-6 (IL-6)-mediated hyperinflammation may contribute to the high mortality of coronavirus disease 2019 (Covid-19). Tocilizumab, an IL-6 receptor blocking monoclonal antibody, has been repurposed for Covid-19, but prospective trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::780ec8d6bde20cab19021335fa6bdf14
Publikováno v:
Cancer and Metastasis Reviews. 37:519-544
The cell plasma membrane serves as a nexus integrating extra- and intracellular components, which together enable many of the fundamental cellular signaling processes that sustain life. In order to perform this key function, plasma membrane component
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf1c19239ad5a7fa2dad62c8850aab7
https://doi.org/10.1007/s10555-018-9733-1
https://doi.org/10.1007/s10555-018-9733-1
Publikováno v:
Blood. 138:4013-4013
Background Rituximab induction (RI) and bendamustine-rituximab (BR) induction are both options for the frontline management of indolent non-Hodgkin lymphomas (NHLs). Although BR induces longer progression-free survival than RI, BR confers more toxici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbed74f399ec7e948320d5797e2c88a2
https://doi.org/10.1182/blood-2021-151136
https://doi.org/10.1182/blood-2021-151136